SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $569,716 | -56.2% | 27,683 | 0.0% | 0.01% | -50.0% |
| Q2 2023 | $1,301,655 | +14.4% | 27,683 | +2.1% | 0.01% | +25.0% |
| Q1 2023 | $1,138,165 | +10.0% | 27,125 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,034,548 | -2.6% | 27,125 | 0.0% | 0.01% | -11.1% |
| Q3 2022 | $1,062,215 | +21.2% | 27,125 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $876,138 | +2477.3% | 27,125 | +2541.2% | 0.01% | – |
| Q1 2022 | $33,994 | +219.0% | 1,027 | +1432.8% | 0.00% | – |
| Q1 2019 | $10,656 | +79.4% | 67 | +8.1% | 0.00% | – |
| Q4 2018 | $5,939 | -33.3% | 62 | -1.6% | 0.00% | – |
| Q3 2018 | $8,899 | -99.7% | 63 | -99.7% | 0.00% | -100.0% |
| Q1 2018 | $2,977,000 | +6.2% | 18,484 | +8.6% | 0.04% | +9.4% |
| Q4 2017 | $2,804,000 | – | 17,026 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |